6-mercaptopurine (6-MP)

DRUG2 trials

Sponsors

Dana-Farber Cancer Institute, Haukeland University Hospital

Conditions

Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia, AdultMyelodysplastic Syndromes, Adult

Phase 1

A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients

RecruitingNCT06199557

Haukeland University HospitalAcute Myeloid Leukemia, Adult, Myelodysplastic Syndromes, Adult

Start: 2024-05-23End: 2029-09-30Target: 48Updated: 2025-06-29

Phase 2

A Study in Adults With Untreated Acute Lymphoblastic Leukemia

CompletedNCT00136435

Dana-Farber Cancer InstituteAcute Lymphoblastic Leukemia

Start: 2002-06-30End: 2011-05-31Updated: 2025-10-20